| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |